Literature DB >> 21933190

International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009.

W K Roth1, M P Busch, A Schuller, S Ismay, A Cheng, C R Seed, C Jungbauer, P M Minsk, D Sondag-Thull, S Wendel, J E Levi, M Fearon, G Delage, Y Xie, I Jukic, P Turek, H Ullum, V Tefanova, M Tilk, R Reimal, J Castren, M Naukkarinen, A Assal, C Jork, M K Hourfar, P Michel, R Offergeld, L Pichl, M Schmidt, V Schottstedt, E Seifried, F Wagner, M Weber-Schehl, C Politis, C K Lin, W C Tsoi, J O'Riordan, A Gottreich, E Shinar, V Yahalom, C Velati, M Satake, N Sanad, I Sisene, A H Bon, M Koppelmann, P Flanagan, O Flesland, E Brojer, M Lętowska, F Nascimento, E Zhiburt, S S Chua, D Teo, S Levicnik Stezinar, M Vermeulen, R Reddy, Q Park, E Castro, A Eiras, I Gonzales Fraile, P Torres, B Ekermo, C Niederhauser, H Chen, S Oota, L J Brant, R Eglin, L Jarvis, L Mohabir, J Brodsky, G Foster, C Jennings, E Notari, S Stramer, D Kessler, C Hillyer, H Kamel, L Katz, C Taylor, S Panzer, H W Reesink.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21933190     DOI: 10.1111/j.1423-0410.2011.01506.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  55 in total

1.  Validation of Virus NAT for HIV, HCV, HBV and HAV Using Post-Mortal Blood Samples.

Authors:  Knut Gubbe; Yvonne Scharnagl; Steffi Grosch; Torsten Tonn; Michael Schmidt; Kai M Hourfar; Andreas Karl; Erhard Seifried; Ina Wilkemeyer; Ulrich Kalus
Journal:  Transfus Med Hemother       Date:  2012-11-13       Impact factor: 3.747

Review 2.  Emerging Pathogens - How Safe is Blood?

Authors:  Michael Schmidt; Wolf-Jochen Geilenkeuser; Walid Sireis; Erhard Seifried; Kai Hourfar
Journal:  Transfus Med Hemother       Date:  2013-12-27       Impact factor: 3.747

Review 3.  Current testing strategies for hepatitis C virus infection in blood donors and the way forward.

Authors:  Neelam Marwaha; Suchet Sachdev
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

4.  Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany.

Authors:  Michael Chudy; Julia Kress; Jochen Halbauer; Margarethe Heiden; Markus B Funk; C Micha Nübling
Journal:  Transfus Med Hemother       Date:  2013-12-19       Impact factor: 3.747

Review 5.  Genetic variation of occult hepatitis B virus infection.

Authors:  Hui-Lan Zhu; Xu Li; Jun Li; Zhen-Hua Zhang
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

6.  The results of nucleic acid testing in remunerated and non-remunerated blood donors in Lithuania.

Authors:  Vytenis Kalibatas; Lina Kalibatienė
Journal:  Blood Transfus       Date:  2013-07-25       Impact factor: 3.443

Review 7.  Occult hepatitis B virus infection and blood transfusion.

Authors:  Dong Hee Seo; Dong Hee Whang; Eun Young Song; Kyou Sup Han
Journal:  World J Hepatol       Date:  2015-03-27

8.  The potential complexity and need for caution when interpreting atypical human immunodeficiency virus reactivity in blood donors.

Authors:  Philip Kiely; Mike Catton; Dianne Brown; Doris Chibo; Theo Karapanagiotidis; Denis Spelman
Journal:  Blood Transfus       Date:  2015-07-16       Impact factor: 3.443

9.  Introducing Pathogen Reduction Technology in Poland: A Cost-Utility Analysis.

Authors:  Maria Agapova; Elzbieta Lachert; Ewa Brojer; Magdalena Letowska; Piotr Grabarczyk; Brian Custer
Journal:  Transfus Med Hemother       Date:  2015-04-16       Impact factor: 3.747

Review 10.  Transfusion transmission of HCV, a long but successful road map to safety.

Authors:  Suganya Selvarajah; Michael P Busch
Journal:  Antivir Ther       Date:  2012-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.